The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)

Clinical trial NCT00043862 · COMPLETED

Trial details

NCT number: NCT00043862
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Small Cell Small Cell Lung Cancer

Start date: 2002-08-01
Primary completion: 2005-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.